BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,956 | +12.9% | 80,124 | -25.6% | 0.00% | 0.0% |
| Q1 2023 | $203,655 | -21.2% | 107,754 | -25.0% | 0.00% | 0.0% |
| Q4 2022 | $258,595 | -26.3% | 143,664 | -30.9% | 0.00% | 0.0% |
| Q3 2022 | $351,000 | -45.2% | 207,893 | -20.2% | 0.00% | -50.0% |
| Q2 2022 | $641,000 | -43.2% | 260,484 | -36.1% | 0.00% | -33.3% |
| Q1 2022 | $1,129,000 | -29.6% | 407,423 | +35.4% | 0.00% | 0.0% |
| Q4 2021 | $1,604,000 | -36.1% | 301,002 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $2,511,000 | -50.3% | 296,806 | -28.3% | 0.01% | -45.5% |
| Q2 2021 | $5,049,000 | +69.5% | 414,187 | +237.4% | 0.01% | +37.5% |
| Q1 2021 | $2,978,000 | -26.3% | 122,766 | -2.7% | 0.01% | -33.3% |
| Q4 2020 | $4,043,000 | – | 126,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
| NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
| CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
| Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
| Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
| Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
| RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
| Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
| Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |